COMMUNIQUÉS West-GlobeNewswire

MemoTril Product Information Updated as Consumer Interest in Brain Health and Cognitive Support Supplement Options Grows in 2026
11/02/2026
Examining MemoTril ingredient disclosures, category context for brain health and memory support supplements, and the transparency factors consumers consider when comparing cognitive support options in 2026 New York, NY [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
11/02/2026
Bagsværd, Denmark, 11 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
11/02/2026
REDWOOD CITY, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to transforming chronic condition [...]
Sanofi: Information concerning the total number of voting rights and shares – January 2026
11/02/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
EssilorLuxottica: EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors
11/02/2026
EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors Paris, France (11 February 2026 – 6:00pm) – During its meeting today, EssilorLuxottica Board of Directors decided to propose to the Shareholders’ [...]
Alvotech Announces Increase in Number of Own Shares
11/02/2026
REYKJAVIK, ICELAND (February 11, 2026) — Alvotech (NASDAQ: ALVO) (the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, has increased [...]
VALNEVA Declaration of shares and voting rights: January 31, 2026
11/02/2026
VALNEVA Declaration of shares and voting rights January 31, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint-Joseph [...]
Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies
11/02/2026
CHICAGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the expansion of its digital [...]
CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH
11/02/2026
CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment of Shah Teelani [...]
OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners
11/02/2026
LONDON and NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
EssilorLuxottica: Q4/FY 2025 Results - Revenue growing 18.4% in Q4 and 11.2% in the FY. Adj. operating margin at 16.0% in the FY
11/02/2026
Revenue 1 growing 18.4% in Q4 and 11.2% in the FY Adj. operating margin 1 ,2 at 16.0% in the FY Group’s revenue at Euro 28,491 million in the FY, +11.2% at constant exchange rates 1 , with Q4 at +18.4% North America, [...]
Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation
11/02/2026
DETROIT, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Entirety Biomedical, a Michigan-based medical device startup developing bioabsorbable implant systems with its proprietary Curasorb technology, today announced the closing of a [...]
VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026
11/02/2026
VALNEVA Déclaration d’actions et de droits de vote 31 janvier 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : Îlot [...]
Booking Health Releases 2026 Global Overview of Leading Cancer Hospitals Amid Growing Demand for International Oncology Care
11/02/2026
Langenfeld, Germany, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Booking Health , an international medical travel coordination service, today released a comprehensive 2026 overview of leading cancer hospitals worldwide, [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions – JANVIER 2026
11/02/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
EssilorLuxottica: Le Conseil d’administration d’EssilorLuxottica propose la nomination de huit administrateurs et administratrices
11/02/2026
Le Conseil d’administration d’EssilorLuxottica propose la nomination de huit administrateurs et administratrices Paris, France (11 février 2026 – 18h00) – Réuni aujourd’hui, le Conseil d’administration d’ [...]
Bay Area Lyme Foundation Highlights Research Leadership and Momentum in Tick-Borne Disease, Names New Executive Director
11/02/2026
Milestones include FDA-cleared diagnostics enabled by Lyme Disease Biobank, the launch of Bay Area Lyme Ventures, and 10 years since Lyme Disease Biobank provided its first samples, advancing the field PORTOLA VALLEY, [...]
EssilorLuxottica: Résultats T4 et annuels 2025 - Hausse de +18,4 % du chiffre d'affaires au T4 et de +11,2 % sur l'exercice. Marge opérationnelle ajustée à 16,0 % sur l'exercice
11/02/2026
Hausse de +18,4 % du chiffre d'affaires 1 au T4 et de +11,2 % sur l'exercice Marge opérationnelle ajustée 1,2 à 16,0 % sur l'exercice Chiffre d’affaires annuel du Groupe à 28 491 millions d’euros, +11,2 % à taux de [...]
Outlook Therapeutics Submits Type A Meeting Request to FDA Following Complete Response Letter
11/02/2026
ISELIN, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, [...]

Pages